While walking out of my Doctors office today, I saw a professional looking gentleman walk out of the Endocronologists office across the hall.
I saw him again in the lobby downstairs and had to ask, I said, "are you an Endo or a patient?" He replied, neither, I am a pharmaceutical rep.
I asked if he knew about Afrezza, He had, so I asked if sales are increasing from his perspective. Unfortunately, he said no.
In his opinion, the spirometry test was the biggest impediment, explaining how the Doctors schedules are always full and they just dont want to add anything more to it. I replied with how simple the test is, how they can charge for it, etc, and he said that he realized that, and went on to say that it was not just the time constraints, unfortunately, the doctors are also reluctant to change.
I realize that this is not groundbreaking news to any of us, and I am sharing this encounter because I am wondering if MNKD is able to, or if they already are working with the FDA to get that test eliminated. Or if that is even possible?
I realize that insurance coverage is improving, ads have begun, and progress is being made, albeit slowly, but the spirometry testing
may be hurting sales more than calculated.
We spoke for awhile and he commented on how passionate and knowledgable I was about AFREZZA.
He jokingly said that I should get a job with MNKD promoting it.
I guess 8 years of owning stock in MNKD, having almost $300,000.00 invested, to say that MNKD has my focus would be an understatement!
I sure hope we get to fruition!
And clearly, I am not alone!
Sorry such a long post, just trying to be thorough.
GLTA!
